Top compounds associated with response to PARD6B


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.22 0.0006
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.12 0.0009
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA AZ628 GDSC1000 pan-cancer AAC -0.2 0.001
mRNA Crizotinib FIMM pan-cancer AAC 0.53 0.001
mRNA Erlotinib gCSI pan-cancer AAC 0.21 0.001
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GDC-0941 FIMM pan-cancer AAC 0.52 0.002
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.11 0.003
Download CSV